Tick-Borne Encephalitis Virus Envelope Antibodies

Target Information

Tick-Borne Encephalitis Virus (TBEV) envelope protein, commonly referred to as protein E, is integral to the virus's structure and infectious capability. This glycoprotein is embedded in the viral lipid bilayer and is responsible for mediating attachment and entry into host cells. The E protein functions by binding to receptors on the surface of host cells, facilitating fusion between the viral and cellular membranes. Structurally, the envelope protein contains several domains: a stem-anchor region that is crucial for membrane fusion, and three domains (DI, DII, DIII) that are involved in receptor binding and immune evasion. Protein E is also a primary target for neutralizing antibodies, making it a key focus in vaccine development and serological diagnostics for TBEV. Research on the molecular biology of the E protein has led to advancements in understanding its role in pathogenesis and has driven efforts to develop subunit vaccines using virus-like particles (VLPs) that mimic the native envelope protein's structure, providing protective immunity against TBEV.

Synonyms

TBEV envelope protein